Comfort Systems USA Contingent consideration fair value adjustments decreased by 23.4% to $10.37M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 175.9%, from $3.76M to $10.37M. Over 4 years (FY 2021 to FY 2025), Contingent consideration fair value adjustments shows an upward trend with a 43.8% CAGR.
Increases often signal that acquired assets are performing better than expected, requiring higher future payouts, while decreases may suggest lower-than-anticipated success in R&D milestones.
This reflects the periodic adjustments to the fair value of earn-out provisions or milestone payments related to past bu...
Standard for R&D-heavy firms that frequently acquire biotech companies with milestone-based deal structures.
operating_business_combination_contingent_consideration__7f0be7| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$4.58M | $1.24M | -$3.30M | -$4.09M | $115.00K | $3.44M | $5.35M | $2.38M | $3.10M | $8.73M | $9.40M | $12.49M | $14.69M | $17.25M | $43.71M | $3.76M | $4.07M | $12.10M | $13.54M | $10.37M |
| QoQ Change | — | +127.2% | -365.0% | -24.0% | +102.8% | >999% | +55.4% | -55.5% | +30.1% | +181.7% | +7.7% | +32.9% | +17.6% | +17.5% | +153.3% | -91.4% | +8.4% | +197.2% | +11.9% | -23.4% |
| YoY Change | — | — | — | — | +102.5% | +176.8% | +262.2% | +158.3% | >999% | +153.5% | +75.7% | +424.4% | +374.1% | +97.7% | +365.0% | -69.9% | -72.3% | -29.9% | -69.0% | +175.9% |